Praxis Pharmaceuticals Inc.

Praxis Pharmaceuticals Inc. focuses on the discovery, development and commercialisation of low molecular weight carbohydrate drugs for the treatment of inflammatory diseases and tissue injury. Praxis' novel therapeutic agents target large markets for which current therapies are inadequate or ineffective. Corporate strategy includes accelerated regulatory approval and market penetration by focusing on low-risk indications for its products and maximising product opportunities by entering into late-stage collaborations. The operating strategy to achieve that mission is twofold: 1. Acquisition of licenses for agents to apply in new therapeutic categories. 2. Internal development of new carbohydrate based drugs. Praxis' drugs are intended to be used for treating inflammatory disorders and aiding tissue repair in a range of situations including skin and internal wound repair and wrinkles.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: North America , Europe , Asia

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: